HEMORRHAGIC CEREBROSPINAL FLUID NEURAL STEM CELLS
PCT/EP2019/063888; US 17/059,083; EP 19726702.4
The present invention provides a novel method to isolate neural stem cells (NSCs) from the cerebrospinal fluid (CSF) of preterm infants with intraventricular haemorrhage (IVH) suitable as advanced therapy for the autologous treatment of infants with IVH or for developing allogeneic therapies for different neurological disorders.
1. CSF-NSCs are directly isolated from discarded liquid obtained during neuroendoscopic irrigation performed as treatment of PHH, so pose no ethical concerns. 2. CSF-NSCs are phenotypically stable through passages and adequately proliferate maintaining a stable karyotype. 3. Gene-expression profile of our cells is closer to foetal NSCs than to IPS-derived NSCs, bone marrow mesenchymal or cord blood hematopoietic stem cells. However, CSF-NSCs overexpress 112 markers that differentiate them from foetal NSCs which can be useful to isolate them. 4. Fibroblast-like cells can be isolated from these samples meaning that non-hemorragic CSF can be a new source for fibroblast/mesenchymal stem cells isolation.



.jpg)